ArticleJournal of the American Society of Nephrology : JASN2019

Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.

Taishi Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.